Dr. Peter S. Pang is the Associate Chief / Clinical Affairs in the Department of Emergency Medicine and an Assistant Professor of Emergency Medicine at Northwestern University Feinberg School of Medicine, with a joint appointment in the Department of Medicine. He attended medical school at the University of Texas Health Science Center at San Antonio followed by residency at the Harvard Affiliated Emergency Medicine Residency, a combined Brigham and Women’s / Massachusetts General Hospital program, where he was honored to serve as Chief Resident. He then moved to Chicago and joined the faculty at Northwestern in 2004.

In a short period of time, Dr. Pang has distinguished himself as a clinician, teacher, leader, and emerging investigator. In 5 years, Dr. Pang has risen within the department to become its Associate Chief. During this time period, he has led multiple efforts to not only improve the quality of care patients receive, but also ensuring sound financial stewardship.

Recently, under the mentorship of Dr. Mihai Gheorghiade, Dr. Pang has emerged as a rising clinical researcher in the field of acute heart failure syndromes. He is currently an ad hoc reviewer for multiple journals and has authored or co-authored a substantial number of peer-reviewed publications. In addition, he serves as a national faculty member for the Heart Course, in which he has taught several hundred emergency physicians about the acute management of heart failure.

Dr. Pang’s research has focused on clinical development of novel therapies for acute heart failure with a primary interest in the role of the emergency department/early intervention. The interface of the ED with the rest of the health care system in terms of heart failure management is being actively explored. Currently, Dr. Pang is studying the extent and severity of acute injury in acute heart failure syndromes. If injury occurs early during patients’ presentation, this might represent a unique pathophysiologic target for future intervention.

At present, he serves as an International PI and Co-Chair for a Phase IIIb study. He is a member of several international steering committees for clinical development programs, a member of data safety monitoring board for a national trial, and a scientific advisor for multiple clinical development programs.